The "Circulating Biomarkers and Extracellular Vesicles Europe 2024" conference has been added to ResearchAndMarkets.com's offering.

Industry professionals and prominent academics are poised to gather at the notable Circulating Biomarkers & Extracellular Vesicles Europe 2024 Conference, set to take place at the Hilton Rotterdam in Netherlands on 24th and 25th June 2024.

This pivotal conference serves as a confluence of pioneering research, insightful biomarker analyses, and progressive therapeutic development, focused on the utilization of circulating biomarkers such as cfDNA, CTCs, Exosomes, and Extracellular Vesicles (EVs).

Innovation in Liquid Biopsies and Circulating Biomarkers

The conference agenda is highly anticipated for highlighting cutting-edge advancements in the field of liquid biopsies, utilizing circulating cell-free DNA (cfDNA), circulating tumour cells (CTCs), and other significant biomarkers discovered in bodily fluids. Emphasis will be placed upon the incorporation of advanced tools and technologies, originating from allied disciplines, designed to augment these diagnostic endeavors.

A Synergy of Expertise and Technology

Prominent figures and key opinion leaders will share their insights through comprehensive presentations, panel discussions, and round-table workshops. These sessions form the bedrock of discourse at the conference, offering valuable knowledge exchange and fostering a robust networking environment across multiple disciplines.

Moreover, companies and vendors pivotal to this sector will showcase their latest products and services, encapsulating a broad spectrum of technology innovation originating from commercial enterprises. These contributions are crucial to the ongoing dialogue and will be featured through exhibits and technology spotlight presentations, enriching the conference program.

An Interdisciplinary Assembly with Extensive Networking Opportunities

Registered delegates will have full access to the co-located and concurrent conference tracks to mix-and-match presentations and maximize networking:

• Lab-on-a-Chip and Microfluidics Europe 2024
• Point-of-Care, Biosensors & Mobile Diagnostics Europe 2024
• Organoids and Spheroids Europe 2024
• Circulating Biomarkers and Extracellular Vesicles Europe 2024

The Circulating Biomarkers & Extracellular Vesicles Europe 2024 Conference is scheduled to present a platform aimed at driving forward the biomedical field through innovation and collaboration.

This event promises to underscore the synergy between academic research and industry-led innovation while serving as a catalyst for future advancements in the field of circulating biomarkers and extracellular vesicles.

Conference Agenda:

Monday, 24 June 2024

Session Title: Advances in Technologies and Research Efforts in Circulating Biomarkers and Extracellular Vesicles -- 2024

• Nanospresso: Microfluidic Mixing of Nucleic Acids and Excipients to Make Nanomedicines
  • Raymond Schiffelers, Professor of Nanomedicine, University Medical Center Utrecht, Netherlands
• Beckman Coulter Life Sciences Innovative Flow Cytometry For Counting and Characterization of Extracellular Vesicles
  • Andreas Wicovsky, Sr. Global Market Development Manager Research Flow Cytometry, Beckman Coulter Life Sciences
• Particle Metrix GmbH NTA - More than Size and Concentration
  • Ingrid Bloss, Sales Manager Europe, Particle Metrix GmbH
• Izon Science Extracellular Vesicles: Paving the Way to Automation and Standardization in Precise Isolation and Single-particle Characterization
  • Stephane Mazlan, Regional Director (EMEA), Izon Science
• EV MEET Cell: An Efficient EV-Target Cell Interaction through Modulation of the Extracellular Environment of Target Cell
  • Sai Kiang Lim, Research Director, Institute of Medical Biology, A*STAR, Singapore
• EV-based Therapeutics Development: No Place for the Weak
  • Mario Gimona, Head of Manufacturing, GMP Unit, Paracelsus Medical University Salzburg, Austria
• ExoPulseT Production Platform: 1st, 2nd and 3rd Generation EV
  • Marcin Jurga, Chief Scientific Officer, EXO Biologics SA, Belgium
• NanoFACS Isolated Placental Cell- and Size-Specific EVs and T-cell Polarization
  • Terry Morgan, Professor of Pathology and Laboratory Medicine, Oregon Health and Science University, United States of America

Tuesday, 25 June 2024

Session Title: Biomarkers, Diagnostics and EVs: Regulation and Business

• Recent Developments in IVDR, Including LDTs
  • Erik Vollebregt, Partner, Axon Lawyers, Netherlands
• The Power of Scalable POC-Manufacturing in Challenging Times (PPWR, REACH, EU-Legislation)
  • Wouter Geurts, Business Development Manager - FILMS , TEKNI-PLEX , Belgium
• Integrating Microphysiological Systems and Extracellular Vesicle-Based Technologies to Advance Regenerative Medicine
  • Danilo Tagle, Director, Office of Special Initiatives, National Center for Advancing Translational Sciences at the NIH (NCATS), United States of America

For more information about this report visit https://www.researchandmarkets.com/r/rn236d

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240611795203/en/